Comparison Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 49.13 USD | +1.03% |
|
+2.01% | +11.53% |
| 09-25 | Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says | MT |
| 09-24 | Truist Lifts Price Target on Scholar Rock Holding to $77 From $76, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | +1.03% | +2.01% | +11.53% | +26.79% | +54.25% | 5.92B |  |  |  |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
